JOB vs RYOJ

The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. While the balance sheet shows strong liquidity (Current Ratio 5.32) and very low leverage (Debt/Equity 0.08), these are offset by deteriorating operations, including a -14.60% YoY revenue decline and a dismal ROE of -51.07%. The low valuation metrics (P/B 0.50, P/S 0.27) appear to be a value trap rather than a discount, as the company is shrinking and consistently unprofitable. Technical trends are completely bearish (0/100), suggesting no immediate market confidence.

Despite a strong Piotroski F-Score of 7/9 indicating short-term financial health improvements, RYOJ is fundamentally broken from a valuation and growth perspective. The stock trades at a massive premium to its Graham Number ($0.34) and Intrinsic Value ($0.07), with a P/E ratio of 205.00 that is unsustainable given the severe revenue contraction of -34.30% YoY. Negative operating margins and a total collapse in technical trend (0/100) suggest a company in a steep decline despite its current liquidity.